KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Cash from Financing Activities (2016 - 2025)

AbbVie (ABBV) has disclosed Cash from Financing Activities for 14 consecutive years, with -$4.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 39.28% to -$4.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$12.7 billion, a 144.18% decrease, with the full-year FY2025 number at -$12.7 billion, down 144.18% from a year prior.
  • Cash from Financing Activities was -$4.2 billion for Q4 2025 at AbbVie, up from -$4.6 billion in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $10.8 billion in Q1 2024 to a low of -$9.6 billion in Q4 2022.
  • A 5-year average of -$3.9 billion and a median of -$4.3 billion in 2023 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: tumbled 128.95% in 2021, then skyrocketed 274.73% in 2024.
  • AbbVie's Cash from Financing Activities stood at -$6.3 billion in 2021, then tumbled by 52.0% to -$9.6 billion in 2022, then skyrocketed by 53.82% to -$4.4 billion in 2023, then tumbled by 54.21% to -$6.9 billion in 2024, then skyrocketed by 39.28% to -$4.2 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Cash from Financing Activities are -$4.2 billion (Q4 2025), -$4.6 billion (Q3 2025), and -$2.7 billion (Q2 2025).